On May 21, 2021, TSD Life Sciences Co.,Ltd. closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10,040 KRW | +11.18% | -2.05% | -25.74% |
1st Jan change | Capi. | |
---|---|---|
-25.74% | 165M | |
-36.44% | 8.68B | |
-3.29% | 3.2B | |
+19.31% | 2.71B | |
-18.71% | 2.04B | |
-22.03% | 1.64B | |
+64.58% | 1.43B | |
+34.58% | 841M | |
-7.42% | 718M | |
-25.51% | 538M |
- Stock Market
- Equities
- A217330 Stock
- News Cytogen, Inc.
- TSD Life Sciences Co.,Ltd. announced that it has received KRW 2.9999853 billion in funding from Cytogen, Inc.